Co-diagnostics, inc. shares list of upcoming industry conferences and events for november 2023

Salt lake city , oct. 31, 2023 /prnewswire/ -- co-diagnostics, inc. (nasdaq-cm: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the list of events it has chosen to exhibit at or attend during november, 2023, which strategically align with its mission of increasing accessibility of affordable gold-standard pcr diagnostics around the world. at each event, the company will discuss its upcoming at-home and point-of-care co-dx™ pcr platform technology*, which has been designed to bring pcr diagnostics to the point-of-care as the world adjusts to a post-pandemic diagnostics landscape.
CODX Ratings Summary
CODX Quant Ranking